On-Site Clinical Trials

Research Match, funded in part by the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program, is a quick and simplified way to search the studies available on ClincalTrials.gov. 

The following clinical trials are active at the ILD Collaborative or at Partner Centers.

The purpose of this study is to provide an initial evaluation of the effectiveness of BMS-986278 in participants with lung fibrosis [idiopathic pulmonary fibrosis (IPF) and progressive fibrotic interstitial lung disease (PF-ILD)], to demonstrate the safety of BMS-986278, and provide information on the drug levels of BMS-986278 in these participants.
The study will utilize pre-post survey measures to evaluate Project ECHO for ILD with respect to an initial set of practice and clinical outcomes and relies on questionnaire data obtained from providers participating in Project ECHO for ILD at baseline, at 6 months, and at study end.
The study will assess whether patients of providers participating in Project ECHO for ILD experience reduced stress, including financial stress, based on their ability to receive timely and local care and services, The study will employ nested mixed-method design at baseline, at 6 months and at 12 months to answer the study question.
The purpose of this research study is to build and maintain a registry of people with interstitial lung disease (ILD). Medical information collected for this registry may be used to advance ILD and pulmonary research and improve patient care. This is an observational registry. Participants will not receive any investigational treatments or investigational drugs as part of their participation in this registry.